Skin News and Research

RSS

Advances in leadless pacing: an interview with Dr. Reddy

Pacemakers have been around for a very long time, they're great devices, critical for many people who have slow heartbeats. While they're very effective, they have some issues. There are two main aspects relating to these issues.

1 Dec 2015

Novel class of antimicrobials could be effective in fighting drug-resistant MRSA infection

A novel class of antimicrobials that inhibits the function of a key disease-causing component of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the major drug-resistant bacterial pathogens, according to researchers at Georgia State University.

1 Dec 2015

American Academy of Dermatology releases Chronic Hives Patient App

Patients who are struggling with chronic hives can turn to a new free tool for help. This month, the American Academy of Dermatology released its Chronic Hives Patient App, which offers tools and resources for chronic hives management.

30 Nov 2015

Researchers discover drug target and genetic pathway for graft-versus-host disease

A Seattle Children's Research Institute lab has discovered a genetic pathway that can be targeted with existing drugs to prevent graft-versus-host disease (GVHD), a common and deadly complication of bone marrow transplants.

30 Nov 2015

Dermetel holds 5K road race to raise funds for production of skin cancer awareness documentary

Non-profit organization Dermetel announced today that they will begin production on a short documentary to raise awareness about skin cancer. The documentary aims to focus on the often-parasitic relationship between indoor tanning bed companies and young women, and highlights how skin image insecurities fostered by an unhealthy advertising and indoor tanning bed culture often lead to skin cancer diagnoses.

28 Nov 2015

Six-month markers predict long-term cGVHD outcomes

Researchers have identified measures early in the course of chronic graft-versus-host disease that predict long-term prognosis in haematopoietic cell transplantation recipients.

27 Nov 2015

Columbia University data scientists create world's first catalog of therapeutic venom

What doesn't kill you could cure you. A growing interest in the therapeutic value of animal venom has led a pair of Columbia University data scientists to create the first catalog of known animal toxins and their physiological effects on humans.

26 Nov 2015

New drug may show promise against resistant melanomas

A new drug discovered by scientists at Sanford Burnham Prebys Medical Discovery Institute may show promise for treating skin cancers that are resistant or unresponsive to today's leading therapies.

25 Nov 2015

Orthopedic surgeon creates world's first internal bone-lengthening device for young children

An orthopedic surgeon is creating the world's first implantation device that can lengthen the bones of young children internally. The inventor, a physician at Texas Tech University Health Sciences Center El Paso, expects the device will lead to fewer infections and less pain, making the bone-lengthening process more bearable for children.

25 Nov 2015

Researchers offer novel solution to promote successful radiotherapy for cancer patients

Researchers at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai have discovered a key mechanism by which radiation treatment (radiotherapy) fails to completely destroy tumors. And, in the journal Nature Immunology, they offer a novel solution to promote successful radiotherapy for the millions of cancer patients who are treated with it.

25 Nov 2015

Fat cells produced from bone marrow may be linked to chronic diseases

Researchers at the University of Colorado Anschutz Medical Campus have found that fat cells produced by stem cells from the bone marrow may be linked to chronic illnesses like diabetes, cardiovascular disease, kidney disease and some cancers.

25 Nov 2015

Portrazza approved to treat patients with advanced squamous non-small cell lung cancer

The U.S. Food and Drug Administration today approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer.

24 Nov 2015

New collaboration aims to develop novel generation artificial pancreas

Debiotech SA, the ARTORG Center for Biomedical Engineering Research of the University of Bern - and the Division of Endocrinology, Diabetes and Clinical Nutrition of the Bern University Hospital "Inselspital" are proud to announce the start of an exclusive collaboration to develop a novel generation artificial pancreas.

24 Nov 2015

Researchers reveal causal association between aneuploidy and cancer

Publication in Nature Cell Biology: researchers at the Université libre de Bruxelles - ULB Cancer Research Center, U-CRC - show the causal link between aneuploidy and cancer.

24 Nov 2015

Heightened levels of psychological stress associated with skin complaints in college students

College is a stressful time in the lives of students, and a new study by researchers at the Lewis Katz School of Medicine at Temple University and Temple University found that heightened levels of psychological stress are associated with skin complaints.

24 Nov 2015

BioThrax approved to prevent disease after exposure to anthrax spores

The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.

24 Nov 2015

Compared to monotherapy combination of pills for advanced skin cancer extends survival

The combination of cobimetinib and Zelboraf® (vemurafenib) has been shown to extend the lives of previously untreated patients with advanced skin cancer to nearly two years (22.3 months)

23 Nov 2015

EMBL scientists develop new laser technique to prevent cells from contracting

You were once a hollow shell. To sculpt that hollow ball into an organism with layers of internal organs, muscle and skin, portions of that embryonic 'shell' folded inwards. The same happens to fruit fly embryos, and researchers at the European Molecular Biology Laboratory in Heidelberg, Germany, have now identified a particular group of cells which are crucial for the first such fold.

23 Nov 2015

Ninlaro (ixazomib) approved to treat people with multiple myeloma

Today the U.S. Food and Drug Administration granted approval for Ninlaro (ixazomib) in combination with two other therapies to treat people with multiple myeloma who have received at least one prior therapy.

21 Nov 2015

Innovative microbiome technology may help fight certain infections

Stony Brook University and Ortek Therapeutics, Inc. announced today that two patent applications were filed in the United States and internationally for nutrient based compositions utilizing an innovative microbiome technology that may help combat certain infections.

20 Nov 2015

Skin News and Research

Advances in leadless pacing: an interview with Dr. Reddy

Novel class of antimicrobials could be effective in fighting drug-resistant MRSA infection

American Academy of Dermatology releases Chronic Hives Patient App

Researchers discover drug target and genetic pathway for graft-versus-host disease

Dermetel holds 5K road race to raise funds for production of skin cancer awareness documentary

Six-month markers predict long-term cGVHD outcomes

Columbia University data scientists create world's first catalog of therapeutic venom

New drug may show promise against resistant melanomas

Orthopedic surgeon creates world's first internal bone-lengthening device for young children

Researchers offer novel solution to promote successful radiotherapy for cancer patients

Fat cells produced from bone marrow may be linked to chronic diseases

Portrazza approved to treat patients with advanced squamous non-small cell lung cancer

New collaboration aims to develop novel generation artificial pancreas

Researchers reveal causal association between aneuploidy and cancer

Heightened levels of psychological stress associated with skin complaints in college students

BioThrax approved to prevent disease after exposure to anthrax spores

Compared to monotherapy combination of pills for advanced skin cancer extends survival

EMBL scientists develop new laser technique to prevent cells from contracting

Ninlaro (ixazomib) approved to treat people with multiple myeloma

Innovative microbiome technology may help fight certain infections

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News